Please login to the form below

Not currently logged in
Email:
Password:

antibodies

This page shows the latest antibodies news and features for those working in and with pharma, biotech and healthcare.

Regeneron’s COVID-19 antibody cocktail reduces viral load and alleviates symptoms

Regeneron’s COVID-19 antibody cocktail reduces viral load and alleviates symptoms

Investigational treatment also helped patients recover faster. Regeneron has released new data for its investigational COVID-19 antibody cocktail, and the early results are promising. ... Although the dataset is relatively small and had not yet been peer

Latest news

More from news
Approximately 31 fully matching, plus 1,117 partially matching documents found.

Latest Intelligence

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    American oncology specialist Incyte invested $100m for a monoclonal antibody production site in Yverdon (Vaud). ... Over 1, 000 biotech start-ups work in fields ranging from orthopaedics or dermatology, through to antibodies, oncology, neurology and more.

  • Surviving cancer: a new era for patients Surviving cancer: a new era for patients

    Monoclonal antibodies have given rise to many promising therapies with equally promising clinical results. ... One such example is through the development of antibody-drug conjugates (ADC) – monoclonal antibodies attached to biologically active

  • BiTE* platform and the evolution toward off-the-shelf immuno-oncology approaches BiTE* platform and the evolution toward off-the-shelf immuno-oncology approaches

    The reason the molecule is called ‘bispecific’ is that it is engineered from not one but two antibodies: one is designed to engage with CD3, which is found on T cells;

  • Gut instincts lead Takeda to GI pipeline success Gut instincts lead Takeda to GI pipeline success

    The success has been hard won. Entyvio, a monoclonal antibody, was shrouded with early theoretical safety concerns that clipped expectations until a suite of innovative and comprehensive trials reported positively and

  • The search for treatments for Parkinson’s disease The search for treatments for Parkinson’s disease

    Pfizer is probably in that category, so its move was not totally deflating, particularly as, in virtually the same week, Takeda said it was getting into CNS and developing an antibody

More from intelligence
Approximately 1 fully matching, plus 120 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 35 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 18 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios

MadMicrobe is an award-winning team of animators and science experts creating photo real life-science animation content for the healthcare and...

Latest intelligence

Covid-19 redefines rules of customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs...
Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians....
The concordance conundrum: understanding the complexities of behaviour change
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....

Infographics